Akebia Therapeutics reported $10.48M in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 2.67M 0.28M
Agios Pharmaceuticals AGIO:US $ 0.44M 0.1M
Akebia Therapeutics AKBA:US $ 10.48M 12.54M
Alnylam Pharmaceuticals ALNY:US $ 40.81M 5.18M
Amgen AMGN:US $ 1510M 51M
Ardelyx ARDX:US $ 0.14M 0.05M
Astellas Pharma 4503:JP Y 88870M 29955M
AstraZeneca AZN:LN 156386.94M 17145.23M
Bayer BAYN:GR € 5680M 504M
Biomarin Pharmaceutical BMRN:US $ 123.13M 6.16M
Exelixis EXEL:US $ 13.48M 0.28M
Fresenius Medical Care FME:GR € 3411M 120.73M
GlaxoSmithKline GSK:LN 213600M 55400M
Intercept Pharmaceuticals ICPT:US $ 0.31M 0.45M
Johnson & Johnson JNJ:US $ 7919M 321M
Karyopharm Therapeutics KPTI:US $ 939K 487K
Moderna Inc MRNA:US 1.38B 364M
Nektar Therapeutics NKTR:US $ 5.12M 0.2M
Opko Health OPK:US $ 194.31M 49.56M
Ptc Therapeutics PTCT:US $ 9.64M 0.5M
Regeneron Pharmaceuticals REGN:US $ 297.1M 107.8M
Sarepta Therapeutics SRPT:US $ 37.8M 6.35M
Seattle Genetics SGEN:US $ 106.1M 18.47M
Vanda Pharmaceuticals VNDA:US $ 6.06M 0.39M